In the BioHarmony Drug Report Database
Emete-con (benzquinamide) is a small molecule pharmaceutical. Benzquinamide was first approved as Emete-con on 1982-01-01. It is used to treat nausea and vomiting in the USA. The pharmaceutical is active against D(2) dopamine receptor and prostaglandin G/H synthase 2.
Image (chem structure or protein)